Tirzepatide catalogue pricing is quoted per box of 10 vials, not per vial. Current first‑party USD list prices (per box of 10 vials) are: 5 mg × 10 vials – $54; 10 mg × 10 vials – $74; 15 mg × 10 vials – $94; 20 mg × 10 vials – $116; 30 mg × 10 vials – $152; 40 mg × 10 vials – $193; 50 mg × 10 vials – $242; 60 mg × 10 vials – $278; 100 mg × 10 vials – $425; 120 mg × 10 vials – $515. The minimum order quantity (MOQ) is one box for every listed strength. These figures are first‑party catalogue quotes; a formal written quotation may confirm or adjust the final amount. All products are designated for laboratory research use only.
Current Tirzepatide quote table for laboratory research
The following table summarises the catalogue pricing for Tirzepatide research peptide. Prices are listed in USD and apply to a box containing 10 vials. The minimum order is one box for each strength.
| SKU | Specification (per box) | Price (USD/box) | MOQ |
|---|---|---|---|
| TR5 | 5 mg × 10 vials | 54 | 1 box |
| TR10 | 10 mg × 10 vials | 74 | 1 box |
| TR15 | 15 mg × 10 vials | 94 | 1 box |
| TR20 | 20 mg × 10 vials | 116 | 1 box |
| TR30 | 30 mg × 10 vials | 152 | 1 box |
| TR40 | 40 mg × 10 vials | 193 | 1 box |
| TR50 | 50 mg × 10 vials | 242 | 1 box |
| TR60 | 60 mg × 10 vials | 278 | 1 box |
| TR100 | 100 mg × 10 vials | 425 | 1 box |
| TR120 | 120 mg × 10 vials | 515 | 1 box |
All prices are first‑party catalogue list quotes. A formal quotation should be obtained to confirm pricing, particularly for non‑standard quantities, custom documentation requirements, or when a binding commitment is needed for procurement. No per‑vial pricing is offered; the box of 10 vials is the smallest trade unit.
Tirzepatide research peptide specifications
Tirzepatide (research code LY3298176) is a 39‑amino‑acid synthetic peptide. Its molecular formula is C225H348N48O68 and the molecular weight is approximately 4813.45 g/mol. The CAS number assigned to the compound is 2023788-19-2.
The peptide is documented to engage both the glucose‑dependent insulinotropic polypeptide (GIP) receptor and the glucagon‑like peptide‑1 (GLP‑1) receptor, a dual receptor profile that makes it a valuable research tool for investigating incretin‑receptor biology and downstream signaling pathways in laboratory models.
- CAS Number: 2023788-19-2
- Research Code: LY3298176
- Peptide Length: 39 amino acids
- Molecular Formula: C225H348N48O68
- Molecular Weight: Approximately 4813.45 g/mol
- Receptor Profile: Dual GIP / GLP‑1 receptor agonist
- Format: Lyophilized powder
- Purity Option: ≥99% by HPLC
- Standard Packaging: 10 vials per box
- Application: Research use only
Batch‑specific certificates of analysis (COA), HPLC traces, and mass spectrometry (MS) documentation are available to qualified laboratories as part of the documentation package. The lyophilized presentation is intended for standard laboratory workflows and reconstitution protocols under controlled research conditions.
How to request a formal laboratory research quotation
To request a binding quotation for Tirzepatide research peptide, use the product page at https://gemaihealth.com/product/tirz/. When submitting an enquiry, clearly specify the required SKU (TR5 through TR120) and the number of boxes. This allows the quotation to be matched precisely to the catalogue specification.
Because only catalogue list prices are published, any variation in order quantity or any need for additional documentation—such as an extended analytical data package, specific sterility reports, or custom vial labeling—must be handled through a manual quotation. No extrapolated or pro‑rata price is provided online, and all formal purchase terms (including shipping, lead time, and payment conditions) are issued exclusively in the written quote.
All Tirzepatide material supplied through this channel is designated exclusively for research use and is not for human or veterinary use. Institutions should ensure that their inquiry is consistent with internal research compliance and procurement policies.
Additional identification sources
For substance identity verification, two public databases provide independent records for Tirzepatide:
- PubChem: The compound is listed under a PubChem CID that supports CAS 2023788-19-2. View PubChem entry.
- NIH/NCATS Inxight: Drugs: The record for substance identifier OYN3CCI6QE further corroborates the chemical identity. View NCATS Inxight entry.
These references are provided solely for chemical identification context and do not serve as product order pages or sources of pricing information.
For laboratory research only. Not for human or veterinary use.
For research use only. Not for human or veterinary use.
